Tenet Healthcare Co. (NYSE:THC) Shares Sold by O Shaughnessy Asset Management LLC

O Shaughnessy Asset Management LLC decreased its position in Tenet Healthcare Co. (NYSE:THC - Free Report) by 9.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 37,835 shares of the company's stock after selling 3,978 shares during the quarter. O Shaughnessy Asset Management LLC's holdings in Tenet Healthcare were worth $4,776,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. WR Wealth Planners LLC grew its position in shares of Tenet Healthcare by 2,836.4% in the fourth quarter. WR Wealth Planners LLC now owns 323 shares of the company's stock valued at $41,000 after purchasing an additional 312 shares during the period. Smartleaf Asset Management LLC increased its stake in shares of Tenet Healthcare by 30.5% during the 4th quarter. Smartleaf Asset Management LLC now owns 471 shares of the company's stock valued at $59,000 after acquiring an additional 110 shares during the last quarter. Kestra Investment Management LLC acquired a new stake in shares of Tenet Healthcare in the fourth quarter worth approximately $60,000. Wilmington Savings Fund Society FSB grew its holdings in Tenet Healthcare by 1,352.8% in the fourth quarter. Wilmington Savings Fund Society FSB now owns 523 shares of the company's stock valued at $66,000 after purchasing an additional 487 shares during the period. Finally, Spire Wealth Management raised its stake in Tenet Healthcare by 19.5% during the fourth quarter. Spire Wealth Management now owns 558 shares of the company's stock worth $70,000 after purchasing an additional 91 shares during the period. 95.44% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at Tenet Healthcare

In other Tenet Healthcare news, Director J Robert Kerrey sold 9,525 shares of Tenet Healthcare stock in a transaction on Tuesday, March 11th. The shares were sold at an average price of $125.43, for a total value of $1,194,720.75. Following the completion of the transaction, the director now owns 27,378 shares of the company's stock, valued at $3,434,022.54. The trade was a 25.81 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this link. Insiders own 0.93% of the company's stock.

Tenet Healthcare Stock Down 0.0 %

Shares of Tenet Healthcare stock traded down $0.06 on Monday, hitting $120.29. 2,542,054 shares of the company's stock traded hands, compared to its average volume of 1,521,133. The stock has a market cap of $11.44 billion, a P/E ratio of 3.73, a PEG ratio of 1.02 and a beta of 1.77. The firm's 50-day moving average is $131.75 and its 200 day moving average is $140.96. The company has a quick ratio of 1.70, a current ratio of 1.78 and a debt-to-equity ratio of 2.25. Tenet Healthcare Co. has a 52-week low of $90.03 and a 52-week high of $171.20.

Tenet Healthcare (NYSE:THC - Get Free Report) last issued its earnings results on Wednesday, February 12th. The company reported $3.44 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.95 by $0.49. Tenet Healthcare had a net margin of 15.48% and a return on equity of 21.88%. Equities analysts anticipate that Tenet Healthcare Co. will post 12.24 earnings per share for the current year.

Analyst Ratings Changes

Several research analysts recently weighed in on THC shares. Cantor Fitzgerald reaffirmed an "overweight" rating and issued a $177.00 target price on shares of Tenet Healthcare in a research report on Thursday, February 13th. The Goldman Sachs Group lowered Tenet Healthcare from a "buy" rating to a "neutral" rating and reduced their price objective for the company from $196.00 to $140.00 in a research note on Monday, December 16th. KeyCorp dropped their target price on shares of Tenet Healthcare from $200.00 to $185.00 and set an "overweight" rating for the company in a research report on Tuesday, January 7th. Truist Financial reduced their price target on shares of Tenet Healthcare from $190.00 to $175.00 and set a "buy" rating on the stock in a research report on Monday, January 6th. Finally, Barclays cut their target price on shares of Tenet Healthcare from $190.00 to $161.00 and set an "overweight" rating on the stock in a research note on Thursday, February 13th. Three equities research analysts have rated the stock with a hold rating, fifteen have issued a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $166.41.

About Tenet Healthcare

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.